Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View

Despite considerable psychotherapeutic advancement since the discovery of chlorpromazine, almost one third of patients with schizophrenia remain resistant to dopamine-blocking antipsychotics, and continue to be exposed to unwanted and often disabling side effects, but little if any clinical benefit....

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Cheryl Cheuk-Yan, Gadelrab, Romayne, Ntephe, Chukwuma Uchenna, McGuire, Philip K., Demjaha, Arsime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735262/
https://www.ncbi.nlm.nih.gov/pubmed/31551822
http://dx.doi.org/10.3389/fpsyt.2019.00601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735262/
https://www.ncbi.nlm.nih.gov/pubmed/31551822
http://dx.doi.org/10.3389/fpsyt.2019.00601

Ejemplares similares